- Doctors for COVID Ethics have been warning about the potential for gene-based COVID-19 “vaccines” to cause blood clots, cerebral vein thrombosis and sudden death
- SARS-CoV-2 spike protein binds to the ACE2 receptor on platelets. The subsequent activation of the platelets can lead to disseminated intravascular coagulation (DIC), i.e., a pathological overstimulation of your coagulation system resulting in abnormal blood clotting, thrombocytopenia (low platelet count) and hemorrhaging
- Research shows deaths are 14.6 times more frequent during the first 14 days after the first COVID injection among people over the age of 60, compared to those who aren’t vaccinated. Other data also show that after COVID-19 vaccines were implemented, overall death rates have, with few exceptions, increased
- A key problem with all of these gene-based COVID-19 vaccines is that the spike protein itself appears toxic, and your body is now a spike protein-producing factory
- Its inherent toxicity may be due to it being a prion protein. If so, we can expect these injections to cause all manner of prion diseases, such as Alzheimer’s, Parkinson’s and Lou Gehrig’s disease (ALS)
February 28, 2021, Dr. Sucharit Bhakdi, a retired professor, microbiologist and infectious disease and immunology specialist, along with several other doctors and scientists who have formed Doctors for COVID Ethics, sent a letter1 to the European Medicines Agency (EMA), warning about the potential for gene-based COVID-19 “vaccines” to cause blood clots, cerebral vein thrombosis and sudden death.
The signees listed several questions in need of urgent answers, including evidence that gene-based vaccines will not enter the bloodstream and disseminate throughout the body, or that the vaccines will not remain entrapped in circulation and taken up by endothelial cells.
They warned that, barring such evidence, “it must be expected that during expression of the vaccines’ nucleic acids, peptides derived from the spike protein will be presented via the MHC I – pathway at the luminal surface of the cells,” and that many healthy individuals have CD8-lymphocytes that recognize these kinds of peptides — either due to previous COVID-19 infection, or cross-reaction with other coronaviruses responsible for the common cold.
“We must assume that these lymphocytes will mount an attack on the respective cells,” they noted, unless there’s evidence to exclude this probability.
If lymphocytes do mount an attack on cells, “it must be expected that endothelial damage with subsequent triggering of blood coagulation via platelet activation will ensue,” they warned, adding that reduced platelet count and the appearance of D-dimers in the blood is also to be expected, as are “myriad ischemic lesions throughout the body including in the brain, spinal cord and heart,” followed by “profuse bleedings and hemorrhagic stroke.”